Log in to save to my catalogue

Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome wit...

Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome wit...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1811882827

Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified

About this item

Full title

Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified

Publisher

New York: Elsevier Inc

Journal title

Modern pathology, 2016-08, Vol.29 (8), p.854-864

Language

English

Formats

Publication information

Publisher

New York: Elsevier Inc

More information

Scope and Contents

Contents

The distinction between chronic eosinophilic leukemia, not otherwise specified and idiopathic hypereosinophilic syndrome largely relies on clonality assessment. Prior to the advent of next-generation sequencing, clonality was usually determined by cytogenetic analysis. We applied targeted next-generation sequencing panels designed for myeloid neopl...

Alternative Titles

Full title

Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1811882827

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1811882827

Other Identifiers

ISSN

0893-3952

E-ISSN

1530-0285

DOI

10.1038/modpathol.2016.75

How to access this item